MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
81.10
-0.41
-0.50%
After Hours: 81.10 0 0.00% 18:09 12/16 EST
OPEN
81.56
PREV CLOSE
81.51
HIGH
82.51
LOW
80.77
VOLUME
340.63K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
52.50
MARKET CAP
1.82B
P/E (TTM)
49.74
1D
5D
1M
3M
1Y
5Y
1D
AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer
NASDAQ · 14h ago
SNY Stock Down on Double Trouble With Multiple Sclerosis Drug
NASDAQ · 14h ago
KYTX Stock Rallies 23% on Upbeat Stiff Person Syndrome Study Data
NASDAQ · 15h ago
FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer
NASDAQ · 1d ago
GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU
NASDAQ · 1d ago
Weekly Report: what happened at ANIP last week (1208-1212)?
Weekly Report · 1d ago
ANI Pharmaceuticals Sr. VP Meredith Cook Reports Sale of Common Shares
Reuters · 4d ago
GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea
NASDAQ · 4d ago
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.